Skip to content
E2 · Observational studyCohortPEM unclearCross-sectionalPeer-reviewed
Standard · 3 min

Gut microbiota dysbiosis in Post-COVID condition symptoms: relation with chronic fatigue and functional limitation.

Carpallo-Porcar, Beatriz, García-Martínez, Laura, Jiménez-Sánchez, Carolina et al.

BMC microbiology2026DOIPubMed

Design
Cross-sectional
Participants
Not reported
PEM required
Unclear
Case definition
Not stated in the abstract

Quick Summary

Researchers studied the gut bacteria of 30 people with Post-COVID condition and 20 healthy controls, looking for differences that might relate to fatigue and reduced physical function. They observed some differences in specific bacterial types between groups, but these associations weakened or disappeared after accounting for digestive symptoms and other factors. The authors describe their findings as exploratory and note that larger studies are needed before drawing firm conclusions.

Why It Matters

By analogy, understanding whether distinct gut bacterial signatures associate with Post-COVID phenotypes (including those resembling ME/CFS) may inform mechanistic hypotheses relevant to ME/CFS. However, relevance to ME/CFS is unclear, as this study involved Post-COVID patients without confirmed ME/CFS case definitions, and the observed associations were largely confounded by digestive symptoms and other factors.

Observed Findings

What the study reports it measured.

  • Escherichia/Shigella was enriched in Post-COVID patients with ME/CFS-like symptoms compared to controls, both overall and in the subgroup without functional limitation.
  • Streptococcus and Veillonella were observed at higher relative abundance in controls compared to Post-COVID patients.
  • Flavonifractor and Hungatella were observed at higher relative abundance in Post-COVID patients without ME/CFS-like symptoms.
  • These bacterial associations attenuated after adjustment for digestive symptoms and vaccine dose, with none remaining statistically significant.
  • PICRUSt2 analysis identified predicted functional pathway differences in nucleotide and amino acid metabolism, but none survived multiple-testing correction.

Inferred Conclusions

What the authors interpret from those results.

  • The authors propose that phenotype-associated taxonomic differences may exist within Post-COVID condition despite the absence of global diversity alterations.
  • They hypothesise that observed bacterial differences may be partly driven by confounding variables (digestive symptoms, vaccine history) rather than representing primary pathophysiological signals.
  • They suggest that larger, integrated omics studies (metagenomic and metabolomic) are needed to validate exploratory findings and clarify potential clinical relevance.

Remaining Questions

  • Do the identified bacterial associations remain significant in larger, more homogeneous Post-COVID cohorts with standardised case definitions?
  • To what extent do digestive symptoms confound or mediate the relationship between microbiota composition and Post-COVID fatigue phenotypes?
  • Do predicted metabolic pathway alterations reflect genuine functional changes, and do they correlate with other biomarkers (e.g., metabolites, immune markers)?
  • By analogy, might similar microbiota signatures associate with ME/CFS specifically, and if so, do they differ from Post-COVID patterns?

What This Study Does Not Prove

This cross-sectional study does not establish whether microbiota differences cause fatigue or functional limitation, nor does it confirm that observed bacterial patterns drive Post-COVID pathophysiology. The associations do not generalise beyond the 50 Spanish participants studied, and the exploratory nature of the findings—combined with attenuation after covariate adjustment—means they should not be interpreted as treatment targets or diagnostic markers. Relevance to ME/CFS specifically remains unestablished, as the cohort was Post-COVID and case definitions were not formally applied.

Explore further

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Cite this study

The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.

Primary citation

Carpallo-Porcar, Beatriz, García-Martínez, Laura, Jiménez-Sánchez, Carolina, Calvo, Sandra, & Roig, Francisco J (2026). Gut microbiota dysbiosis in Post-COVID condition symptoms: relation with chronic fatigue and functional limitation.. BMC microbiology. https://doi.org/10.1186/s12866-026-05527-1

BibTeX

@article{mecfsatlas-carpallo-porcar-2026-gut-microbiota,
  author  = {Carpallo-Porcar, Beatriz and García-Martínez, Laura and Jiménez-Sánchez, Carolina and Calvo, Sandra and Roig, Francisco J},
  title   = {Gut microbiota dysbiosis in Post-COVID condition symptoms: relation with chronic fatigue and functional limitation.},
  journal = {BMC microbiology},
  year    = {2026},
  doi     = {10.1186/s12866-026-05527-1},
  note    = {PubMed: 43021070},
  url     = {https://www.mecfsatlas.com/evidence/carpallo-porcar-2026-gut-microbiota},
}

Atlas snapshot reference

ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-13. https://www.mecfsatlas.com/evidence/carpallo-porcar-2026-gut-microbiota

Contribute

Private, reviewed by a human. Not a public comment thread.